Search Login Register

GYKI 52466 Summary

Description: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Also Known As: 1-(p-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride; GYKI-52466; Benzenamine, 4-(8-methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)-

Networked: 76 relevant articles (12 outcomes, 7 trials/studies) for this Bio-Agent

Key Diseases for which GYKI 52466 is Relevant

  1. Seizures (Seizure) : 10 outcomes 2 studies in 34 results
  2. Ischemia : 1 outcome 1 study in 8 results
  3. Brain Injuries (Brain Injury) : 1 outcome in 3 results
  4. Infarction : 1 outcome in 2 results
  5. Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) : 1 study in 2 results
Show All >>

Drugs Related to GYKI 52466

  1. alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)
  2. N-Methylaspartate (NMDA)
  3. 2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)
  4. Dizocilpine Maleate (Dizocilpine)
  5. Excitatory Amino Acid Antagonists
  6. Kainic Acid (Kainate)
  7. AMPA Receptors (AMPA Receptor)
  8. Kainic Acid Receptors (Kainate Receptor)
  9. GYKI 53655
  10. N-Methyl-D-Aspartate Receptors (NMDA Receptors)
Show All >>

Therapies Related to GYKI 52466

  1. Aftercare (After-Treatment)

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.